Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09LGT
|
||||
Former ID |
DIB020124
|
||||
Drug Name |
kallstroemin D
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [543131] | ||
Structure |
Download2D MOL |
||||
Formula |
C51H82O20
|
||||
InChI |
InChI=1S/C51H82O20/c1-21-10-15-50(63-19-21)22(2)34-32(69-50)17-30-28-9-8-26-16-27(11-13-48(26,6)29(28)12-14-49(30,34)7)66-45-42(60)40(58)38(56)33(67-45)20-62-47-44(41(59)37(55)24(4)65-47)70-51(18-31(52)35(53)25(5)68-51)71-46-43(61)39(57)36(54)23(3)64-46/h8,21-25,27-47,52-61H,9-20H2,1-7H3
|
||||
InChIKey |
JXANHBVHGVNOQZ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | C-X-C chemokine receptor type 3 | Target Info | Antagonist | [527495] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | CXCR3-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.